Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer
International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)
DOI: 10.25258/ijpqa.16.12.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Nehapriya Sinha und 4 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Sinha, N., Rani, V., Raj, A., Kumar, A., & Ahmad, I. (2026). Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.106
Vancouver
Sinha N, Rani V, Raj A, Kumar A, Ahmad I. Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.106
BibTeX
@article{Sinha2026,
author = {Sinha, Nehapriya and Rani, Vibha and Raj, Aman and Kumar, Awadhesh and Ahmad, Imtiaz},
title = {Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {12},
doi = {10.25258/ijpqa.16.12.106}
}
EUVIMED